西点药业：使用自有资金200万元人民币设立全资子公司

Core Viewpoint - The company plans to establish a wholly-owned subsidiary, Xidian Pharmacy Co., Ltd., with an investment of 2 million RMB to enhance market expansion and business development [1] Group 1 - The board of directors will hold the 14th meeting of the 8th session on January 22, 2026, to review the proposal for the establishment of the subsidiary [1] - The new subsidiary will primarily engage in drug retail, the operation of Class III medical devices, and the sale of disinfectant equipment [1] - This investment aligns with the company's strategic development plan and aims to facilitate market expansion [1]